Correlation Between NeoPharm and DongKook Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both NeoPharm and DongKook Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeoPharm and DongKook Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeoPharm LTD and DongKook Pharmaceutical Co, you can compare the effects of market volatilities on NeoPharm and DongKook Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeoPharm with a short position of DongKook Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeoPharm and DongKook Pharmaceutical.

Diversification Opportunities for NeoPharm and DongKook Pharmaceutical

0.68

Correlation Coefficient

NeoPharm  DongKook Pharmaceutical

Poor diversification

The 3 months correlation between NeoPharm and DongKook is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding NeoPharm LTD and DongKook Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DongKook Pharmaceutical and NeoPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeoPharm LTD are associated (or correlated) with DongKook Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DongKook Pharmaceutical has no effect on the direction of NeoPharm i.e., NeoPharm and DongKook Pharmaceutical go up and down completely randomly.

Pair Corralation between NeoPharm and DongKook Pharmaceutical

Assuming the 90 days trading horizon NeoPharm LTD is expected to generate 1.37 times more return on investment than DongKook Pharmaceutical. However, NeoPharm is 1.37 times more volatile than DongKook Pharmaceutical Co. It trades about 0.05 of its potential returns per unit of risk. DongKook Pharmaceutical Co is currently generating about 0.02 per unit of risk. If you would invest  1,120,000  in NeoPharm LTD on September 19, 2024 and sell it today you would earn a total of  80,000  from holding NeoPharm LTD or generate 7.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

NeoPharm LTD  vs.  DongKook Pharmaceutical Co

NeoPharm LTD

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NeoPharm LTD are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, NeoPharm may actually be approaching a critical reversion point that can send shares even higher in January 2025.

DongKook Pharmaceutical

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in DongKook Pharmaceutical Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, DongKook Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with NeoPharm and DongKook Pharmaceutical

The main advantage of trading using opposite NeoPharm and DongKook Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeoPharm position performs unexpectedly, DongKook Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DongKook Pharmaceutical will offset losses from the drop in DongKook Pharmaceutical's long position.

The idea behind NeoPharm LTD and DongKook Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.